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RESUMEN
Objetivos: En el presente trabajo se describe el desarrollo de comprimidos matriciales de clorhidrato 
de diltiazem.
Métodos: Se obtienen comprimidos matriciales mediante el uso de goma guar y HPMC. Se estudian 
distintas formulaciones en las que se cambia la composición de estos materiales matriciales como 
controladores de la cesión. Los comprimidos se prepararon por el método de granulación húmeda 
y se evaluaron uniformidad de contenido, índice de hinchamiento, estabilidad y velocidad de 
liberación.
Resultados: La capacidad de hinchamiento aumenta con el porcentaje utilizado de HPMC. Las 
formulaciones F7, F8 y F9 son las que muestran mejores características de liberación. Los estudios de 
estabilidad de la formulación seleccionada demuestran una buena resistencia a la rotura, capacidad 
de hinchamiento y control de la velocidad de disolución durante el estudio de estabilidad.
Conclusiones: Las formulaciones F7, F8 y F9 tienen unas buenas propiedades de control de liberación 
del fármaco durante al menos 8 horas. La cinética de liberación se pueden ajustar a un orden cero.
PALABRAS CLAVE: HPMC, goma guar, Diltiazem HCl, comprimidos matriciales, liberación 
controlada.
ABSTRACT 
Aim: The present investigation concerns the development of controlled release matrix tablet of 
Diltiazem HCl.
Methods: Matrix tablet of Diltiazem HCl was formulated by using HPMC and Guar gum as a 
polymeric matrix forming materials in various concentrations (%w/w) to study their ability to 
retard the release. The tablets were prepared by wet granulation method and evaluated for physical 
properties, content uniformity, swelling index, stability and in-vitro drug release.
Results: Swelling was increased as the concentration and viscosity of HPMC increases. Tablets 
formulated using guar gum and HPMC alone were gave initial burst effect followed by controlled 
release for 8 hr. It was evident from the study that the formulationsF7,F8 &F9 have optimum swelling 
index and in vitro drug release up to 44% in 8hrs. The stability studies of optimized batch showed 
that there was no change in hardness, swelling index and in-vitro release up to 12 weeks. 
Conclusions: The batches F7, F8 and F9 possessed the high potential to release the drug gradually for 
more than 8 hours. The zero-order release kinetic indicates concentration independent drug release 
ensuring that the formulated tablet showed promising result to be a sustained release formulation.
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INTRODUCTION
Diltiazem HCl, an orally active calcium channel-blocking 
agent, is used in treatment of angina pectoris (variant 
& classical angina), hypertension and arrhythmias.1,2 It 
is highly water soluble drug and is rapidly and almost 
completely (60-70%) absorbed from GIT, followed by 
oral administration, but undergoes extensive hepatic 
metabolism. The biological half-life of drug is 3.5 ± 1.2 h3. 
It is typically administered three or four times daily, in the 
form of conventional tablet. Thus frequently administration 
leads to constant change in blood concentration. To 
overcome the frequently administration and to minimize 
the peak to through oscillation of the blood concentration, 
control release formulation are developed. So, it has desired 
duration of action and localize the dosage form in a specific 
region and control the release rate of drug.3
Guar gum is natural gum and chemically; it is 
galactomannan polysaccharide. The gum consists of the 
pulverized endosperm of the seed of C. tetragonolobous. 
Guar Gum forms viscous colloidal dispersions when 
hydrated in cold water. It is used as a thickening agent 
for lotions and creams in concentration up to 2.5%, tablet 
binder (10%), emulsion stabilizer (1%). Chemically; HPMC 
is mixed alkyl-hydroxyalkyl cellulose ether containing 
methoxyl and hydroxypropyl groups. HPMC also forms 
viscous colloidal solution in cold water. It is used as a film 
former (2-10%), binder (2-5%). High viscosity grades are 
used to retard the release of water- soluble drugs. The 
present study aim to formulating controlled release matrix 
tablet of Diltiazem HCl, with the controlled release soluble 
matrix material (HPMC and Guar gum).4
MATERIAL AND METHODS
Materials
Diltiazem HCl was obtained as a gift sample from 
Sun pharmaceuticals Ltd, Baroda, India. HPMC K4M 
(Methocel®K4M) was obtained from Colorcon Asia Pvt. 
Ltd, Goa. Guar gum was obtained from the laser chemicals, 
Baroda. All other chemicals used were analytical grade and 
double distilled water used throughout the experiments.
Preparation of controlled release tablets of diltiazem
Controlled release tablets were prepared by wet granulation 
method.  Hydroxypropyl methylcellulose, Guar gum was 
used as retardant material for preparation of tablets. Other 
excipients were dicalcium phosphate, magnesium stearate 
as a lubricant and talc as a glident. Distilled water was 
employed as a granulating fluid.
For preparation of controlled release tablets of Diltiazem, 
drug and polymer were weighed accurately, mixed 
thoroughly then other excipients were added and mixed 
by triturating.The resultant mixture was granulated by 
using distilled water and wetted mass pass through the 
20 mesh sieve and retained on 40 mesh sieve. Then it was 
dried at 60°C for half an hour in an oven and processed 
to get 20:40 mesh granules. The dried 20:40 granules 
were mixed with glident(talc) and lubricant (Magnesium 
stearate). After mixing compressed into tablets using a 
Rotary tablet machine (Rimek Rotary tablet machine RSB-4 
mini press) 12 mm die, and punches were used 400 mg is 
adjusted as a weight of each tablet and hardness between 
3-5 kg/cm2.5,6 The composition of formulation is shown in 
(Table-1). These matrix tablets were evaluated for their 
physical properties (Table-2).
Evaluation of formulation:
Physical parameters:
Tablets were tested for hardness, friability, weight variation 
and drug content. Hardness of the tablets was tested using 
a Monsanto hardness tester and Friability of the tablets was 
determined in a Roche friabilator (Model EF2, Electrolab, 
Mumbai, India).7
Drug content:
The prepared tablets were analyzed for Diltiazem HCl 
contents. Tablets were crushed into fine powders and 
          Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9
Diltiazem HCl      120 120 120 120 120 120 120 120 120
Hydroxy propyl
methyl cellulose
30 30 30 40 40 40 50 50 50
Guar gum 30 40 50 30 40 50 30 40 50
Di-Calcium Phosphate 211 201 191 201 191 181 191 181 171
Talc 6 6 6 6 6 6 6 6 6
Magnesium stearate 3 3 3 3 3 3 3 3 3
% of polymer to the total tablet weight 15% 17.5% 20% 17.5% 20% 22.5% 20% 22.5% 25%
F1 to F9 = Designed different batches according to different polymeric HPMC: Guar gum ratio
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Diltiazem HCl was extracted into water by shaking the 
crushed powder with water in a volumetric flask. The 
solution was filtered out and diluted with water and 
estimated in UV-Spectrophotometer (UV-1601, Shimadzu, 
Japan) at 235 nm after suitable dilution.8
Swelling index:
The extent of swelling was measured in terms of % weight 
gain by the tablet. The swelling behavior of formulation F1 
to F9 was studied. One tablet from each formulation was 
kept in a Petri dishcontaining pH 7.2 phosphate buffers. At 
the end of 1 hr, the tablet was withdrawn, kept on tissue 
paper and weighed. Then for 2 hr and every 2 hr, weights 
of the tablet were noted and the process was continued 
for 8hr.The % weight gain by the tablet was calculated by 
formula.9
S.I = {(Mt-M0) / M0} × 100   (1)
Where, S.I = Swelling index; Mt = weight of tablet at time‘t’; 
M0 = weight of tablet at time t = 0
Swelling behavior of controlled release matrix tablets were 
represented in Figure 2.
In-vitro drug release studies:
A tablet was placed in USP XXIII paddle-type dissolution 
test apparatus (Model TDL-08, Electro lab, Mumbai, India) 
and immersed in 900ml of dissolution media phosphate 
buffer (pH 7.2), maintained at 37oC ± 0.5oC.  Aliquot 
samples were withdrawn every hour up to a period of 8 
hours. After each withdrawal, the withdrawn amount of 
dissolution media was replaced with buffer. The absorbance 
of the withdrawn samples, after appropriate dilution was 
measured at 237 nm against appropriate buffer blanks.10, 11
Stability study
Optimized batch of Diltiazen HCl tablets (Formulation F7 
to F9 ) were kept for a short term stability study in high 
Formulation
Hardness
(kg/cm2)
Friability
(%)
Weight 
variation
Thickness
(mm)
Drug 
content (%)
F1 3.58 + 0.75 0.65 402.75 ± 8.44 5.027 ±  0.191 99.56
F2 4.02 + 0.55 0.55 398.8 ± 6.92 5.037 ± 0.057 99.43
F3 3.96 + 0.83 0.65 400.3 ± 6.98 5.103 ± 0.107 98.12
F4 3.68 + 0.57 0.42 398.25 ± 8.03 4.913 ± 0.261 98.16
F5 3.76 + 0.80 0.51 402.6 ± 6.36 4.930 ± 0.044 99.06
F6 4.20 + 0.48 0.44 397.6 ± 6.58 4.973 ± 0.040 97.51
F7 3.95 + 0.62 0.23 398.9 ± 5.75 4.833 ± 0.064 99.74
F8 3.80 + 0.38 0.29 402.45 ± 5.86 5.003 ± 0.176 98.39
F9 4.20 + 0.28 0.16 403.4 ± 6.58 4.948 ± 0.231 98.78
Each reading is an average of three determinations (Avg.± S.D)
Figure 1. Diltiazem HCl release profile from the matrix 
tablets of F1 to F9 batches     
Figure 2. Swelling index of diltiazem HCl matrix 
tablet   
density polyethylene sealed cover at 40 ± 2 ºC / 75 ± 5% RH 
as per ICH Guidelines. Samples were withdrawn for six 
and twelve weeks of storage and evaluated for appearance, 
drug content and in vitro dissolution.
RESULT AND DISCUSSION:
Controlled release matrix tablets were evaluated for its 
Ars Pharm. 2012; 53(4): 16-20.
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Table 3. Comparison of r2 value of zero order Vs 
Higuchi’s diffusion equation
physical characteristics; the results are shown in Table 2. 
Hardness of the tablets was found in the range of 3.58 ± 
0.75 to 4.20 ± 0.28 kg/cm2. Percentage weight loss in the 
friability test was found to be 0.43% in all batches. Content 
uniformity of all the prepared batches is within the limit 
(Diltiazem 100 ± 3% of the labeled content). We can 
conclude that all the batches of tablets prepared were of 
good quality with regard to hardness, friability and drug 
content. 
The matrix tablet was evaluated as a matrix forming 
material for oral controlled release tablets using Diltiazem 
HCl as a model drug. Matrix tablets, each containing 
120mg of Diltiazem, were prepared using different matrix 
forming polymeric material (HPMC and Guar gum).
In-vitro swelling studies
The swelling index of controlled release matrix tablets for 
a period of 8hr was studied. The values obtained as shown 
in the Figure 2. It is evident that an increase in the amount 
of HPMC causes increase in swelling index. Among all the 
formulations F7, F8, and F9 showed the highest value of 
69.8%, 74.9% and 80.5% respectively.
In-vitro release studies
The In-vitro release study showed satisfactory controlled 
release of Diltiazem from all medicated formula. The 
release of Diltiazem HCl from prepared formulations was 
analyzed by plotting cumulative % drug release verses 
time (hr) as shown in Figure 1.
Guar gum and HPMC are hydrophilic swellable polymer 
matrices; they are able to form a viscous gel layer; which 
controls the drug release via diffusion through the gel and 
erosion of the gel barrier. It was observed that as there 
was a reduction in the amount of the polymer to the half 
ensures faster release. This may be attributed due to the 
reduction of the strength of the gel layer, which enhances 
drug diffusion and water uptake through the matrix. It was 
concluded from the results that as there was increases in 
polymer concentration of HPMC the release of drug might 
be slower. This is also supported by Xu and Sunada who 
reported that HPMC content was predominant controlling 
factor.1,2
While using blends of polymers in different batches like 
Batch F7 (HPMC K4M 50 mg and Guar gum 30 mg), Batch 
F8 (HPMC K4M 50 mg and Guar gum 40 mg), and Batch F9 
(HPMC K4M 50 mg and Guar gum 50 mg), the cumulative 
percentage (%) release of batch F7, F8 and F9 were found to 
be 41.91%, 45.55% and 44.13% in 8 hr, respectively.
Method of Bamba and Puisieusx was adopted to study 
model dependent kinetics of drug release for the most 
appropriate model. The dissolution data of all batches were 
fitted to zero-order and Higuchi.13 The result is shown in 
Table 3. From all the formulations F7, F8 and F9 follows 
desired drug profile, i.e. near the zero order drug release.
Stability study
Stability studies of optimized formulations were analyzed 
for 12 weeks by evaluating its hardness, swelling index 
and release study.  Table 4 indicates the stability study data 
of optimized formulations (F7, F8 and F9). It is seen that in 
all three batches, there is no any significance difference in 
hardness, swelling index and in-vitro release study till 12 
week stability study.  It reveals that all three formulations 
(F7, F8 and F9) are stable.
CONCLUSION:
Matrix tablets were prepared by wet granulation method 
using hydroxy propyl methyl cellulose (HPMC) and 
guar gum as a matrix forming materials in different 
proportion. Study indicates that HPMC and Guar gum 
(50:30, 50:40 and 50:50) ratio were found suitable for the 
Batch No
Zero order Higuchi’s  diffusion
r2 r2
F7 0.9944 0.9728
 F8 0.970 0.935
F9 0.992 0.977
Formulation
Parameter
Hardness( kg/cm2) Swelling index Drug release (%)
F7 F8 F9 F7 F8 F9 F7 F8 F9
After 6 
week
3.95 + 0.62 3.80 + 0.38 4.20 + 0.28 69.63± 0.085 74.2 ± 0.023 80.5 ± 0.012 40.91 44.85 43.13
After 12 
week
3.95 + 0.89 3.80 + 0.68 4.20 + 0.80 69.85± 0.013 74.3 ± 0.015 80.75 ± 0.019 40.25 44.69 42.80
Table 4. Stability study of batch F7 to F9
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use as pharmaceutical excipients in the formulation and 
manufacturing of controlled release matrix tablets of 
Diltiazem HCl. The batches F7, F8 and F9 possessed the 
high potential to release the drug gradually for more 
than8 hours. It confirmed the fact that the formulated 
tablet showed promising result to be a sustained release 
formulation. It is evident from overall studies that hydroxy 
propyl methyl cellulose (HPMC) and guar gum possess 
potential for sustained release of Diltiazem HCl from the 
matrix tablet.
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